Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154231 | SCV000203886 | drug response | Tyrosine kinase inhibitor response | 2006-10-28 | no assertion criteria provided | clinical testing | |
Key Laboratory of Carcinogenesis and Cancer Invasion, |
RCV003998241 | SCV004042732 | likely pathogenic | Lung adenocarcinoma | no assertion criteria provided | clinical testing |